Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Galecto Inc (NASDAQ: GLTO)

 
GLTO Technical Analysis
5
As on 10th Nov 2025 GLTO SHARE Price closed @ 17.25 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4.06 & Strong Buy for SHORT-TERM with Stoploss of 0.58 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GLTOSHARE Price

Open 21.44 Change Price %
High 25.88 1 Day 12.30 248.48
Low 15.06 1 Week 9.90 134.69
Close 17.25 1 Month 13.45 353.95
Volume 41523644 1 Year 16.55 2364.29
52 Week High 17.92 | 52 Week Low 0.46
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
WBA 11.98 0.50%
OPEN 7.97 21.49%
NVDA 199.05 5.79%
PLUG 2.56 -3.40%
ONDS 5.88 1.20%
LMDX 0.02 0.00%
BYND 1.34 -3.60%
AKTS 0.04 0.00%
SOFI 30.54 8.26%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
GLTO 17.25 248.48%
NDRAW 0.03 200.00%
ZVZZT 31.96 165.23%
HCVIU 9.00 159.37%
 
NASDAQ USA Top Losers Stocks
COMSP 0.00 -100.00%
FPAY 0.01 -94.74%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
ZIVOW 0.06 -85.00%
ORGS 0.15 -83.52%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
 
 
GLTO
Daily Charts		 GLTO
Intraday Charts		 Whats New @
Bazaartrend		 GLTO
Free Analysis
 
GLTO Important Levels Intraday
RESISTANCE38.10
RESISTANCE31.41
RESISTANCE27.28
RESISTANCE23.15
SUPPORT11.35
SUPPORT7.22
SUPPORT3.09
SUPPORT-3.60
 
GLTO Forecast November 2025
Share
4th UP Forecast17.73
3rd UP Forecast17.58
2nd UP Forecast17.48
1st UP Forecast17.39
1st DOWN Forecast17.11
2nd DOWN Forecast17.02
3rd DOWN Forecast16.92
4th DOWN Forecast16.77
 
GLTO Weekly Forecast
4th UP Forecast17.40
3rd UP Forecast17.35
2nd UP Forecast17.32
1st UP Forecast17.29
1st DOWN Forecast17.21
2nd DOWN Forecast17.18
3rd DOWN Forecast17.15
4th DOWN Forecast17.10
 
GLTO Forecast2025
4th UP Forecast77.45
3rd UP Forecast58.14
2nd UP Forecast46.21
1st UP Forecast34.28
1st DOWN Forecast0.22
2nd DOWN Forecast-11.71
3rd DOWN Forecast-23.64
4th DOWN Forecast-42.95
 
 
GLTO Other Details
Segment EQ
Market Capital 84606824.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
GLTO Address
GLTO
 
GLTO Latest News
 
Your Comments and Response on Galecto Inc
 
GLTO Business Profile
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung. Its products also comprise GB2064, which is in Phase I/IIa for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase I/IIa for the treatment of cancer and fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts. Address: 75 State Street, Boston, MA, United States, 02109
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service